D-Wave's $100M Government Deal Sparks Rally, Insider Exits, and Political Questions
26.05.2026 - 05:31:32 | boerse-global.de
A proposed $100 million equity injection from the US Department of Commerce has sent D-Wave Quantum shares on a tear — but the deal is drawing fire on Capitol Hill just as company insiders cash out. Congresswoman Zoe Lofgren has questioned whether the CHIPS and Science Act, originally designed to boost semiconductor research and manufacturing, legally covers quantum computing funding. She has also flagged potential conflicts of interest involving a former IBM manager who participated in the negotiations, and an IBM-backed joint venture called "Anderon" that stands to receive $1 billion in government support.
The market, however, has paid little heed to the political noise. D-Wave stock shot up 65 percent in seven days, closing at €25.82 on Monday. The 14-day relative strength index sits at 70, a textbook overbought signal, while the share still trades roughly 33 percent below its 52-week high of €38.48. Trading volume tripled to 141.7 million shares during the three-day surge — classic speculative euphoria.
Insiders have been taking profits throughout the rally. Five separate SEC filings since the start of the year document share sales by company executives, the most recent dated May 22. Among them, personnel chief Sophie Ames disposed of about $437,000 in stock on May 20 under a prearranged trading plan. Whether these moves reflect routine tax planning, portfolio diversification, or a more cautious view of the stock's valuation, they temper the narrative of unfettered momentum.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The government funding itself comes with a built-in dilutive sting. D-Wave has signed a letter of intent to issue common shares worth $100 million to the Commerce Department. Once the final contracts are closed, the share count will increase noticeably. The company ended the first quarter with roughly $588 million in cash, but the equity component of the deal means existing holders will see their stakes diluted.
Fundamentally, the picture is mixed. Revenue for the first quarter of 2026 plunged 81 percent year over year to just $2.9 million. Yet bookings hit a record $33.4 million — nearly 20 times the prior-year figure — driven by a $20 million system sale to Florida Atlantic University and a $10 million quantum-computing-as-a-service contract with a Fortune 100 company. D-Wave continues to push its technological roadmap: a 100,000-qubit superconducting annealing system and a 10,000-qubit gate-model machine with roughly 100 logical qubits, targeting quantum chemistry and artificial intelligence.
Wall Street remains broadly bullish. TD Cowen lists D-Wave among the three biggest beneficiaries of the government program, alongside Rigetti Computing and GlobalFoundries. Thirteen analysts rate the stock a buy, none a sell, with a consensus price target of $35.17 and a range of $19.58 to $45. A key test comes on May 28, when management takes the stage at the TD Cowen conference in New York, followed by the company's first-ever investor day on June 1 at the New York Stock Exchange. There, executives are expected to provide details on the final terms of the CHIPS Act funding, the dilution mechanics, and the technology roadmap through 2032. A week later, the "Qubits Europe" customer day in London on June 18 will give clients a chance to gauge progress.
The surge has also lifted competitors: Rigetti, which signed a similar $100 million letter of intent, saw a parallel rally. But with a trailing annualized volatility of nearly 150 percent and a stock that has more than doubled from its lows, D-Wave remains a high-wire act — part government-backed bet, part political lightning rod, and part pure speculation.
Ad
D-Wave Quantum Stock: New Analysis - 26 May
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
